Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Empiric Therapy of Helminth co-Infection to Reduce HIV-1 Disease Progression (THE or PHE)
This study is ongoing, but not recruiting participants.
Study NCT00507221 Information provided by University of Washington
First Received: July 24, 2007 Last Updated: June 26, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Helminthiasis
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Communicable Diseases
Disease Progression
Infection
More general conditions related to this trial
Disease Attributes
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Parasitic Diseases
Pathologic Processes
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Albendazole
Praziquantel
Current standard of care in Kenya
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Anticestodal Agents
Antimitotic Agents
Antineoplastic Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
University of Washington
Centers for Disease Control and Prevention
Kenya Medical Research Institute
Back to top of Main Content
